Bio-Rad Laboratories - 44 Year Stock Price History | BIO
- The all-time high Bio-Rad Laboratories stock closing price was 825.77 on September 02, 2021.
- The Bio-Rad Laboratories 52-week high stock price is 387.99, which is 18.5% above the current share price.
- The Bio-Rad Laboratories 52-week low stock price is 262.12, which is 20% below the current share price.
- The average Bio-Rad Laboratories stock price for the last 52 weeks is 318.98.
Bio-Rad Laboratories Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 318.9311 | 327.9900 | 374.2800 | 263.9700 | 327.4700 | 1.42% |
2023 | 393.2294 | 422.4300 | 503.0000 | 269.3700 | 322.8900 | -23.21% |
2022 | 505.9841 | 735.4200 | 735.4200 | 351.7100 | 420.4900 | -44.35% |
2021 | 675.8090 | 575.2600 | 825.7700 | 547.0100 | 755.5700 | 29.61% |
2020 | 472.1816 | 372.1600 | 643.4500 | 320.0100 | 582.9400 | 57.54% |
2019 | 312.5637 | 228.0800 | 374.2000 | 224.3000 | 370.0300 | 59.34% |
2018 | 277.5328 | 241.4200 | 326.1500 | 220.1000 | 232.2200 | -2.70% |
2017 | 219.5752 | 182.9100 | 271.3000 | 182.9100 | 238.6700 | 30.94% |
2016 | 149.1690 | 136.1900 | 183.4600 | 123.9300 | 182.2800 | 31.46% |
2015 | 137.5260 | 120.3500 | 151.9300 | 113.7700 | 138.6600 | 15.01% |
2014 | 120.8765 | 122.6500 | 133.7300 | 106.4800 | 120.5600 | -2.47% |
2013 | 118.6682 | 107.4600 | 126.0000 | 107.4600 | 123.6100 | 17.67% |
2012 | 102.7218 | 98.0800 | 114.2500 | 92.3000 | 105.0500 | 9.38% |
2011 | 108.0200 | 105.3200 | 126.3400 | 87.5400 | 96.0400 | -7.52% |
2010 | 94.7088 | 97.8700 | 113.6300 | 81.5000 | 103.8500 | 7.66% |
2009 | 78.5782 | 74.4700 | 100.4600 | 53.1000 | 96.4600 | 28.08% |
2008 | 87.1254 | 99.9700 | 108.1000 | 61.5200 | 75.3100 | -27.32% |
2007 | 82.9541 | 82.2200 | 107.5700 | 67.6700 | 103.6200 | 25.57% |
2006 | 68.9380 | 65.4500 | 84.0100 | 57.2500 | 82.5200 | 26.10% |
2005 | 55.5089 | 57.1700 | 66.9000 | 47.0600 | 65.4400 | 14.07% |
2004 | 55.2252 | 58.4100 | 61.9000 | 50.0100 | 57.3700 | -0.52% |
2003 | 48.0377 | 38.2100 | 62.1500 | 33.4000 | 57.6700 | 49.02% |
2002 | 39.7467 | 30.9000 | 50.5100 | 28.1250 | 38.7000 | 22.27% |
2001 | 23.7924 | 16.0500 | 32.5250 | 15.0750 | 31.6500 | 99.06% |
2000 | 12.9794 | 11.3100 | 16.7450 | 10.6250 | 15.9000 | 36.01% |
1999 | 12.2611 | 10.3100 | 14.5000 | 9.4400 | 11.6900 | 11.33% |
1998 | 13.1470 | 13.0600 | 16.8750 | 9.8750 | 10.5000 | -19.60% |
1997 | 13.5673 | 15.1900 | 16.3750 | 11.8100 | 13.0600 | -12.93% |
1996 | 14.6824 | 14.2067 | 18.3100 | 12.1250 | 15.0000 | 5.88% |
1995 | 11.3630 | 9.1267 | 14.1667 | 8.4567 | 14.1667 | 53.15% |
1994 | 6.4240 | 3.5000 | 9.6267 | 3.5000 | 9.2500 | 177.50% |
1993 | 4.7750 | 5.7067 | 5.9167 | 3.3333 | 3.3333 | -41.59% |
1992 | 6.1821 | 6.4167 | 7.1267 | 5.3733 | 5.7067 | -13.32% |
1991 | 7.0525 | 6.0833 | 9.1667 | 5.5433 | 6.5833 | 6.76% |
1990 | 5.8093 | 5.4167 | 7.6667 | 4.2067 | 6.1667 | 15.63% |
1989 | 5.6551 | 5.7067 | 6.5433 | 4.7500 | 5.3333 | -5.88% |
1988 | 6.3804 | 5.2500 | 7.7067 | 4.9167 | 5.6667 | 11.48% |
1987 | 7.6195 | 5.8733 | 10.6667 | 3.7500 | 5.0833 | -11.59% |
1986 | 5.9524 | 5.0556 | 7.6400 | 4.5556 | 5.7500 | 13.74% |
1985 | 3.2334 | 2.1304 | 5.3067 | 2.1304 | 5.0556 | 137.31% |
1984 | 2.2033 | 2.5007 | 2.5185 | 2.0741 | 2.1304 | -14.81% |
1983 | 2.3317 | 1.3511 | 2.8696 | 1.3511 | 2.5007 | 87.56% |
1982 | 1.3124 | 1.5378 | 1.6104 | 0.8696 | 1.3333 | -7.69% |
1981 | 2.4659 | 2.9807 | 3.6667 | 1.2963 | 1.4444 | -51.25% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.168B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $198.127B | 25.27 |
Stryker (SYK) | United States | $138.991B | 31.32 |
Boston Scientific (BSX) | United States | $131.097B | 37.69 |
EssilorLuxottica (ESLOY) | France | $109.895B | 0.00 |
Medtronic (MDT) | Ireland | $103.904B | 15.43 |
Haleon (HLN) | United Kingdom | $43.864B | 28.50 |
Lonza Group Ag (LZAGY) | Switzerland | $42.859B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $36.052B | 18.70 |
ResMed (RMD) | United States | $34.830B | 28.62 |
Terumo (TRUMY) | Japan | $28.875B | 0.00 |
Koninklijke Philips (PHG) | Netherlands | $23.602B | 18.07 |
Zimmer Biomet Holdings (ZBH) | United States | $21.325B | 13.58 |
Insulet (PODD) | United States | $18.698B | 74.46 |
Baxter (BAX) | United States | $15.062B | 9.80 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.781B | 0.00 |
BellRing Brands (BRBR) | United States | $9.800B | 39.43 |
Demant (WILYY) | Denmark | $7.926B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.208B | 14.42 |
Prestige Consumer Healthcare (PBH) | United States | $3.889B | 19.34 |
ICU Medical (ICUI) | United States | $3.840B | 36.56 |
Haemonetics (HAE) | United States | $3.789B | 18.49 |
Perrigo (PRGO) | Ireland | $3.513B | 10.34 |
Envista Holdings (NVST) | United States | $3.218B | 23.97 |
QuidelOrtho (QDEL) | United States | $3.016B | 19.41 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
Neogen (NEOG) | United States | $2.609B | 30.10 |
LeMaitre Vascular (LMAT) | United States | $2.071B | 50.34 |
Green Thumb Industries (GTBIF) | United States | $1.678B | 29.37 |
AtriCure (ATRC) | United States | $1.498B | 0.00 |
InMode (INMD) | Israel | $1.434B | 8.63 |
AdaptHealth (AHCO) | United States | $1.383B | 9.88 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.271B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.968B | 0.00 |
Owens & Minor (OMI) | United States | $0.965B | 7.54 |
CeriBell (CBLL) | United States | $0.964B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.879B | 15.49 |
Evolus (EOLS) | United States | $0.690B | 0.00 |
Omeros (OMER) | United States | $0.597B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.594B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.584B | 25.75 |
Surmodics (SRDX) | United States | $0.568B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.452B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.439B | 0.00 |
Quanterix (QTRX) | United States | $0.403B | 0.00 |
ZimVie (ZIMV) | United States | $0.375B | 31.63 |
Biote (BTMD) | United States | $0.331B | 7.26 |
Valneva SE (VALN) | France | $0.324B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.311B | 29.56 |
Canopy Growth (CGC) | Canada | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
Cerus (CERS) | United States | $0.293B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
Zynex (ZYXI) | United States | $0.263B | 55.00 |
High Tide (HITI) | Canada | $0.242B | 100.33 |
Aurora Cannabis (ACB) | Canada | $0.234B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.207B | 14.29 |
Sanuwave Health (SNWV) | United States | $0.201B | 2.82 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.190B | 0.00 |
Brainsway (BWAY) | Israel | $0.174B | 92.40 |
FitLife Brands (FTLF) | United States | $0.145B | 18.17 |
Jin Medical (ZJYL) | China | $0.133B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.124B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.096B | 10.81 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
Veru (VERU) | United States | $0.095B | 0.00 |
Exagen (XGN) | United States | $0.091B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
Apyx Medical (APYX) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Modular Medical (MODD) | United States | $0.048B | 0.00 |
Safety Shot (SHOT) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.74 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |